Terms ending in 2029
Every in-force patent on Precision Biosciences, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,338,157 | Rationally-Designed Meganuclease Variants of LIG-34 and I-Crei for Maize Genome Engineering In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,683,257 | Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 10,273,524 | Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence | |
| US 10,287,626 | Recognition Sequences for I-Crei-Derived Meganucleases and Uses Thereof In force · Low confidence | Precision Biosciences, Inc. | In force | Low confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.